Meta-analysis shows medications and lifestyle changes reduce biological age — Evidence Review
Published in Nature Medicine, by researchers from Yale School of Medicine
Table of Contents
A new meta-analysis from Yale indicates that certain prescription medications and lifestyle interventions can measurably reduce biological age as assessed by DNA methylation blood tests, while popular over-the-counter supplements generally do not. These findings are largely consistent with existing research, which supports the effectiveness of drugs like metformin and lifestyle changes in slowing biological aging.
- The study’s support for prescription medications (such as metformin and semaglutide) and combined lifestyle interventions aligns with a growing body of evidence that these approaches can slow biological aging, as assessed by DNA methylation clocks and other biomarkers 2 3 6 7.
- Several related studies confirm that dietary improvements, regular physical activity, and caloric restriction can reduce or slow the progression of biological age, supporting the significance of lifestyle modification highlighted by the new Yale findings 6 7 8 9 10 13.
- The limited effect of over-the-counter supplements observed in the Yale study is echoed in the literature, where evidence for most supplements remains weak or inconsistent, while pharmaceutical and lifestyle interventions show more robust and reproducible effects on aging markers 1 2 4 11 12.
Study Overview and Key Findings
Understanding and intervening in the aging process is a major focus in biomedical research, with the goal of prolonging healthspan and reducing age-related diseases. The Yale study addresses a key challenge: identifying which interventions actually alter biological aging, rather than just correlating with health outcomes. By synthesizing data from 51 clinical studies and applying DNA methylation-based biomarkers (epigenetic clocks), the researchers offer a systematic comparison of diverse anti-aging strategies, including prescription drugs, lifestyle interventions, supplements, and medical procedures. This comprehensive analysis provides new insights into which interventions produce measurable changes in biological age and sets a foundation for more rigorous evaluation of anti-aging therapies.
| Property | Value |
|---|---|
| Organization | Yale School of Medicine |
| Journal Name | Nature Medicine |
| Authors | Raghav Sehgal, Albert Higgins-Chen, Daniel Borrus, Jenel F. Armstrong, John Gonzalez, Jessica Kasamoto, Yaroslav Markov |
| Population | Various individuals undergoing anti-aging interventions |
| Sample Size | 51 clinical studies |
| Methods | Meta-Analysis |
| Outcome | Biological age changes from various anti-aging interventions |
| Results | Certain medications and lifestyle changes reduced biological age. |
Literature Review: Related Studies
To situate the new findings within the broader scientific context, we searched the Consensus database, which includes over 200 million research papers. The following queries were used to identify relevant studies:
Below, key themes from the literature are summarized and grouped by topic.
| Topic | Key Findings |
|---|---|
| Which interventions have the strongest evidence for reducing biological aging? | - Prescription drugs such as metformin, rapamycin, senolytics, GLP-1 agonists, and SGLT2 inhibitors show robust effects in slowing aging and delaying age-related diseases in both animal models and human studies 2 3 5. - Combined lifestyle interventions (diet and exercise) and caloric restriction have demonstrated reductions in biological age, as assessed by DNA methylation clocks 6 7 8 9 13. |
| How do lifestyle changes affect biological age and healthspan? | - Improved diet (e.g., Mediterranean diet) and regular physical activity are independently associated with lower biological age and reduced risk of age-related diseases 7 8 9 10. - Stress management and sufficient sleep may also influence epigenetic aging, although the effects are less well studied 9. |
| Are over-the-counter supplements effective for slowing biological aging? | - Most supplements, including resveratrol and NAD+ precursors, show limited or inconsistent effects on biological age in human studies, with stronger evidence for pharmaceuticals and lifestyle interventions 1 2 3 11 12. - Some natural compounds are under clinical investigation, but evidence remains preliminary compared to drugs like metformin or interventions like caloric restriction 3 11. |
| What are the key mechanisms and biomarkers for evaluating anti-aging interventions? | - DNA methylation-based epigenetic clocks (e.g., GrimAge, PhenoAge, DunedinPACE) are widely used to estimate biological age and assess intervention effects 6 7 9 12 13. - Biological age markers can be reversed or slowed by interventions, but it remains unclear whether this translates into longer healthspan or lifespan 6 7 13. |
Which interventions have the strongest evidence for reducing biological aging?
The Yale study’s finding that prescription medications (metformin, semaglutide, anti-TNF drugs) and combined lifestyle interventions (diet plus exercise) are most effective in reducing biological age is strongly supported by related research. Multiple reviews and clinical trials report that these interventions can slow biological aging and delay onset of chronic diseases, as measured by both clinical outcomes and molecular biomarkers.
- Prescription drugs such as metformin, rapamycin, senolytics, and GLP-1 agonists are top-tier candidates for anti-aging therapies with evidence from animal and early human studies 2 3 5.
- Caloric restriction and structured diet/exercise interventions have shown reductions in biological age and slowed progression of age-related markers in randomized controlled trials 6 7 13.
- Both pharmaceutical and lifestyle interventions target key aging mechanisms, such as inflammation, cellular senescence, metabolic regulation, and DNA methylation 1 2 4.
- The new study’s emphasis on measurable changes in DNA methylation clocks adds rigor to claims of anti-aging effects, building on prior work that used diverse and sometimes less specific biomarkers 6 7 13.
How do lifestyle changes affect biological age and healthspan?
The literature strongly supports the role of diet and physical activity in reducing biological age and promoting healthy longevity. Several large cohort studies and clinical trials have found that adherence to healthy dietary patterns (e.g., Mediterranean, low-fat, or low-carb diets) and regular exercise is associated with younger biological age, lower risk of age-related diseases, and improved healthspan.
- Improving diet and increasing physical activity slow the progression of DNA methylation-based aging biomarkers and can even reverse some epigenetic age measures 7 8 9.
- Healthy lifestyle behaviors remain effective across age, sex, and BMI categories, supporting broad applicability 8 10.
- Lifestyle interventions may also improve specific health outcomes, such as cardiovascular health, beyond their effects on biological age 10.
- The Yale study’s findings are congruent with these results, showing consistent reductions in biological age with combined diet and exercise interventions 7 8 9.
Are over-the-counter supplements effective for slowing biological aging?
Both the Yale study and the broader literature indicate that over-the-counter supplements generally have minimal or inconsistent effects on biological age, especially when compared to pharmaceuticals and lifestyle changes. While some natural compounds are under investigation, robust evidence of efficacy in humans is lacking.
- Most supplements, including resveratrol and NAD+ precursors, have not shown consistent or significant effects on slowing biological aging in large human trials 1 2 3 11.
- The promise of supplements seen in preclinical studies has not always translated to measurable benefits in clinical settings 2 11 12.
- Clinical trials of natural compounds are ongoing, but current data favor prescription medications and lifestyle changes for meaningful impact on aging biomarkers 3 11.
- The Yale study’s negative findings regarding supplements reinforce the need for more rigorous evaluation of these popular interventions 1 2 3 11.
What are the key mechanisms and biomarkers for evaluating anti-aging interventions?
Accurate measurement of biological age is crucial for evaluating anti-aging interventions. DNA methylation-based epigenetic clocks have emerged as leading biomarkers, allowing researchers to estimate biological age and track changes over time in response to interventions.
- Modern epigenetic clocks (e.g., GrimAge, PhenoAge, DunedinPACE) are increasingly used in clinical and research settings to assess the effects of anti-aging therapies 6 7 9 12 13.
- Interventions such as diet, exercise, and caloric restriction have been shown to slow the progression of these biomarkers, although the direct link to health outcomes and lifespan remains under investigation 6 7 13.
- The reversibility of DNA methylation patterns suggests that aging is modifiable, at least in part, by targeted interventions 9 12.
- The Yale study applies these advanced biomarkers in a meta-analysis framework, enhancing the comparability and rigor of anti-aging intervention research 6 7 13.
Future Research Questions
While the Yale study and related research offer valuable insights, several critical questions remain unanswered. Further investigation is needed to clarify the mechanisms underlying changes in biological age, the durability and clinical significance of these changes, and the effectiveness of specific interventions in diverse populations.
| Research Question | Relevance |
|---|---|
| Do reductions in epigenetic age translate into long-term health benefits or longevity? | Establishing whether lowering biological age leads to improved healthspan or lifespan is essential for validating the clinical utility of anti-aging interventions 6 7 13. |
| What are the mechanisms underlying the effects of metformin, semaglutide, and anti-TNF drugs on biological age? | Understanding molecular pathways targeted by these drugs can inform the design of next-generation anti-aging therapies and clarify why they are effective in reducing biological age markers 2 3 4 5. |
| How durable are the biological age reductions produced by lifestyle and pharmaceutical interventions? | Determining whether changes in biological age persist after intervention ends is vital for assessing the long-term impact of anti-aging strategies 7 13. |
| Are there specific subpopulations that benefit more from certain anti-aging treatments? | Investigating effects across age, sex, disease status, and genetic backgrounds can help guide personalized anti-aging interventions and address health disparities 8 10. |
| Can newer epigenetic clocks predict intervention effects more accurately than older biomarkers? | The Yale study suggests that updated biomarkers outperform earlier versions; further research could improve the precision and reliability of biological age measurement 6 7 9 13. |
Future research addressing these questions will be instrumental in translating biomarker-based findings into actionable anti-aging interventions and ultimately improving healthspan and longevity.